参考文献/References:
[1] Li Y,Teng D,Shi X,et al.Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American diabetes association:National cross sectional study[J].British Medical Journal,2020,369:997.
[2] Ogurtsova K,Fernandes J,Huang Y,et al.IDF diabetes atlas:Global estimates for the prevalence of diabetes for 2015 and 2040[J].Diabetes Res Clin Pract,2017,128:40-50.
[3] 李小英.葡萄糖激酶在葡萄糖稳态中的核心作用[J].中华糖尿病杂志,2019,11(7):500-502.
[4] Sheng CS,Tian J,Miao Y,et al.Prognostic significance of long-term HbA1c variability for all-cause mortality in the ACCORD trial[J].Diabetes Care,2020,43(6):1185-1190.
[5] Li S,Nemeth I,Donnelly L,et al.Visit-to-visit HbA1c variability is associated with cardiovascular disease and microvascular complications in patients with newly diagnosed type 2 diabetes[J].Diabetes Care,2020,43(2):426-432.
[6] 陈伟国,朱萧玲,常 盼,等.2型糖尿病患者冠状动脉狭窄程度危险因素分析[J].陕西医学杂志,2020,49(6):672-674,686.
[7] 王方圆,袁 斌,孙志萍.糖尿病住院患者个性化护理及对血糖影响临床研究[J].陕西医学杂志,2018,47(7):947-949.
[8] 安文蓉,徐云生,黄延芹.基于数据挖掘的健脾消渴方治疗2型糖尿病临床特点与规律分析[J].中华中医药学刊,2020,38(2):191-194.
[9] 潘宗妃,熊莉华.熊莉华教授从脾论治糖尿病经验[J].陕西中医,2020,41(10):1464-1467.
[10] 苗丁山,王鹤亭,刘 桠,等.从脾主运化探讨肠道菌群-胰岛β细胞远程串扰在糖尿病血糖维稳中的作用[J].中医杂志,2021,62(15):1312-1315.
[11] 刘 毅,冯晓桃,王文健.“脾主运化”理论再认识——“脾主运”与“脾主化”之辨析[J].中医杂志,2011,52(15):1264-1266.
[12] 谢兆桃,周卓宁,郑 鹏,等.从中焦论治2型糖尿病患者餐后血糖波动[J].陕西中医,2021,42(6):764-766.
[13] 陈 源,李振华,岳仁宋.基于中医胃肠积热的2型糖尿病论治探微[J].时珍国医国药,2021,32(9):2229-2230.
[14] 钱秋海,程益春,夏丽英.健脾降糖饮治疗糖尿病临床与实验研究[J].中医杂志,1991,35(11):29-31.
[15] 周 洁,徐云生,李捷,等.健脾消渴方调控自噬改善2型糖尿病大鼠胰岛功能的机制[J].中华中医药杂志,2021,36(8):4556-4560.
[16] Rajas F,Gautier-Stein A,Mithieux G.Glucose-6 phosphate,a central hub for liver carbohydrate metabolism[J].Metabolites,2019,9(12):282.
[17] Toulis KA,Nirantharakumar K,Pourzitaki C,et al.Glucokinase activators for type 2 diabetes:Challenges and future developments[J].Drugs,2020,80(5):467-475.
[18] Matschinsky FM,Wilson DF.The central role of glucokinase in glucose homeostasis:A perspective 50 years after demonstrating the presence of the enzyme in islets of langerhans[J].Front Physiol,2019,10:148.
[19] Gao Q,Zhang W,Li T,et al.The efficacy and safety of glucokinase activators for the treatment of type-2 diabetes mellitus:A meta-analysis[J].Medicine,2021,100(40):e27476.
[20] Choi JM,Seo MH,Kyeong HH,et al.Molecular basis for the role of glucokinase regulatory protein as the allosteric switch for glucokinase[J].Proc Natl Acad Sci U S A,2013,110(25):10171-10176.
[21] Postic C,Shiota M,Niswender KD,et al.Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase[J].J Biol Chem,1999,274(1):305-315.
[22] Oh YS,Lee YJ,Park K,et al.Treatment with glucokinase activator,YH-GKA,increases cell proliferation and decreases glucotoxic apoptosis in INS-1 cells[J].Eur J Pharm Sci,2014,51:137-145.
[23] Oh YS,Seo E,Park K,et al.Compound 19e,a novel glucokinase activator,protects against cytokine-induced beta-cell apoptosis in INS-1 cells[J].Front Pharmacol,2017,8:169.
[24] Fyfe MC,White JR,Taylor A,et al.Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions[J].Diabetologia,2007,50(6):1277-1287.
[25] Tomas A,Jones B,Leech C.New insights into beta-cell GLP-1 receptor and cAMP signaling[J].J Mol Biol,2020,432(5):1347-1366.
[26] 张 鹤,白宇宁,刘绍能,等.现代医学视角下中医“脾主运化”探析[J].北京中医药,2022,41(2):179-181.
相似文献/References:
[1]李向辉,卢文杰.葛黄降糖汤治疗2型糖尿病合并颈动脉硬化临床研究*[J].陕西中医,2019,(5):580.
LI Xianghui,LU Wenjie..Effect of Gehuang Jiangtang decoction on mellitus complicated with carotid arteriosclerosis in type 2 diabetes patients[J].,2019,(4):580.
[2]杨斯皓,马方霞,詹 云.一贯煎合六味地黄汤配合西药治疗2型糖尿病合并非酒精性脂肪肝临床疗效及对患者生活质量的评价*[J].陕西中医,2019,(8):1006.
YANG Sihao,MA Fangxia,ZHAN Yun..Clinical efficacy and quality of life evaluation of Yiguanjian plus Liuwei Dihuang decoction with western medicine in the treatment of type 2 diabetes with nonalcoholic fatty liver disease[J].,2019,(4):1006.
[3]孙晓红,陈学彬△.芪精丹兰汤对伴有左心室舒张功能不全的2型糖尿病合并代谢综合征患者糖脂代谢、心率变异性的影响*[J].陕西中医,2019,(10):1336.
SUN Xiaohong,CHEN Xuebin..Effect of Qijing Danlan decoction on glucose and lipid metabolism and heart rate variability in patients with type 2 diabetes mellitus complicated with MS with left ventricular diastolic dysfunction[J].,2019,(4):1336.
[4]訾 璐,胡小军△,王 玉,等.针刺中脘穴联合自拟茶方对2型糖尿病患者血糖水平的影响*[J].陕西中医,2019,(10):1460.
ZI Lu,HU Xiaojun,WANG Yu,et al.Effect of zhong wan acupuncture combined with selfdesigned tea prescription on blood glucose level in patients with type 2 diabetes mellitus[J].,2019,(4):1460.
[5]文启友,周 伶,马若梦,等.化瘀利尿法论治2型糖尿病探析[J].陕西中医,2021,(6):761.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.021]
[6]谢兆桃,周卓宁,郑 鹏,等.从中焦论治2型糖尿病患者餐后血糖波动[J].陕西中医,2021,(6):764.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.022]
[7]胡全穗,伍宗明.运用中药药对配伍优化消渴病中医防治方案临床研究[J].陕西中医,2021,(8):1084.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.024]
HU Quansui,WU Zongming.Clinical research on optimizing the TCM prevention and treatment of Xiaoke by using compatibility of herb-partners[J].,2021,(4):1084.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.024]
[8]卢 昉,刘晓霞,梁佩玲,等.清热益气降糖方对2型糖尿病患者胰岛α、β细胞功能的影响[J].陕西中医,2021,(10):1400.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.019]
[9]刘厚利,呼兴华,何 莉,等.基于数据挖掘许建秦治疗湿热内蕴型糖尿病用药规律分析[J].陕西中医,2021,(10):1455.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.035]
[10]陈继玲,任珍珍,王劭敏,等.玉泉丸合生脉散联合二甲双胍治疗气阴两虚证2型糖尿病临床研究[J].陕西中医,2021,(11):1553.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.013]
CHEN Jiling,REN Zhenzhen,WANG Shaomin,et al.Efficacy of Yuquan pills with Shengmai powder and metformin tablets in the treatment of T2DM with deficiency of Qi and Yin[J].,2021,(4):1553.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.013]